NASDAQ: RDHL
Redhill Biopharma Ltd Stock Ownership - Who owns Redhill Biopharma?

Insider buying vs selling

Have Redhill Biopharma Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when RDHL insiders and whales buy or sell their stock.

RDHL Shareholders

What type of owners hold Redhill Biopharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Yorkville Advisors Global LP0.00%386,593$386.59kInstitution
Gagnon Securities LLC0.00%86,102$86.10kInstitution
Gamma Investing LLC0.00%4,828$4.83kInstitution
Federation Des Caisses Desjardins Du Quebec0.00%3,388$3.39kInstitution
Rhumbline Advisers0.00%2,678$2.68kInstitution
Eversource Wealth Advisors LLC0.00%38$38.00Institution
Your Advocates Ltd LLP0.00%19$19.00Institution
Ubs Group Ag0.00%18$18.00Institution
Smartleaf Asset Management LLC0.00%5$5.00Institution
Group One Trading LLC0.00%4$4.00Institution

1 of 2

RDHL vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RDHL0.00%0.00%
AKAN63.04%10.77%Net SellingNet Selling
PRFX7.44%0.00%
UPC0.17%0.00%
SHPH0.28%99.72%

Redhill Biopharma Stock Ownership FAQ

Who owns Redhill Biopharma?

Redhill Biopharma (NASDAQ: RDHL) is owned by 0.00% institutional shareholders, 0.00% Redhill Biopharma insiders, and 100.00% retail investors. Yorkville Advisors Global LP is the largest individual Redhill Biopharma shareholder, owning 386,593.00 shares representing 0.00% of the company. Yorkville Advisors Global LP's Redhill Biopharma shares are currently valued at $394.32k.

If you're new to stock investing, here's how to buy Redhill Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.